Top

BY Meagan Raeke

“Every community is unique,” says Ruth Rechis, Ph.D., director of Be Well Communities™, MD Anderson’s place-based strategy for cancer prevention and control. 

Building on MD Anderson’s decades at the forefront of cancer prevention research, Be Well Communities uses best practices to deploy science-based cancer prevention strategies to communities with the greatest need. It brings individuals and organizations...

Two women are standing side-by-side in a garden. A Black woman is cutting a plant while another woman with glasses and red hair looks on.

BY Clayton Boldt, Ph.D.

Scientific discoveries are essential to driving advances in cancer care. From better screening and diagnostic techniques to innovative new...

BY Shanley Chien

Since the discovery of KRAS gene mutations in 1983, researchers have worked to develop new therapies that target this protein when treating...

BY Devon Carter

B-cell lymphoma isn’t one disease. There are about 63 subtypes, with diffuse large B-cell lymphoma (DLBCL) being the most common. A chemotherapy regimen called R-CHOP has been the standard treatment approach since 2002, when the antibody therapy rituximab was added to the chemotherapy regimen CHOP.

Almost 60% of patients find success with R-CHOP. But what about the remaining 40% of B-cell lymphoma patients?

“The success...

Illustration of B-cell lymphoma cell

BY Devon Carter

Last updated Jan. 11, 2022.

First emerging almost three decades ago, monoclonal antibodies are changing the way doctors treat cancer...

BY Clayton Boldt, Ph.D.

In the last decade, immunotherapy has become a viable treatment option for many cancer patients. Unlike radiation and chemotherapy, immunotherapy...

BY Clayton Boldt, Ph.D.

After completing a course of treatment, there are few words that sound better to a patient than “complete remission.” It’s an indication that...

BY Devon Carter

Natural killer cells – or NK cells – are part of our immune system. They patrol our bodies for abnormal cells like cancer and destroy them...

BY Cynthia DeMarco

Lori Shults didn’t know much about clinical trials when she first came to MD Anderson in May 2017. “I thought they involved some people getting...

BY MD Anderson staff

MD Anderson’s Moon Shots Program™ increases the speed at which our experts turn their research into new cancer treatment options for patients...